Together with recent studies examining the role of human RBBP4 in glioblastoma DNA damage repair18 and neuroblastoma tumor progression,19 our study suggests that blocking Rbbp4 activity could prevent cell survival in Rb‐deficient brain cancer through inhibition of Tp53 deacetylation. The gene discussed is TP53; the disease is neuroblastoma.